Invalidity Of A Patent Claiming Antibodies Characterized By

Baxalta Inc. and Baxalta GmbH (Baxalta) appealed a district court decision that the claims of U.S. Patent No. 7,033,590 were invalid for lack of enablement.

Related Keywords

Baxalta Gmbh , Amgen , Circuit The Court , Amgen Inc , Supreme Court , Genentech , Genentech Inc , Baxalta Inc , Federal Circuit , Mondaq , Invalidity Ofa Patent Claiming Antibodies Characterized By Their Function In View Of Amgen , Food , Drugs , Healthcare , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property , Patent , ,